ORF launches biorisk-free growth factor range

By Simon Pitman

- Last updated on GMT

Related tags: Anti-aging skin care, Marketing

Iceland-based ORF Genetics says it has launched its next generation
of growth factors, targeting anti-aging products for the
cosmeceuticals category.

Called ISOKine, the range has been produced using the company's patented Orfeus plant-based expression platform, which is claimed to help ensure the purity, safety and bioactivity of the products. The range has been designed as an alternative to current growth factor offerings on the market that are based on animal or bacteria-derived platforms. Plant-derived growth factor​ Because its growth factor is plant-derived this means that, as well as having a lower risk of toxins or contaminants, it is also a more environmentally friendly and less costly option, the company claims. The technology used to develop the new range means that it is guaranteed to be endotoxin-free - a key challenge that cosmeceutical players have struggled to overcome in the past. But as well as the safety issue, the company claims it can also be competitive on price because of enhanced production techniques. High development price means up-market​ The intensive research and development and processing that goes into growth factors invariably means a high price, which invariably sees the ingredient being incorporated into some of the most expensive anti-aging skin care products on the market. However, the company says that the scalability of its production system means that it will be able to tackle large-scale and bulk quantities of ISOkine at 'competitive prices'. Increasingly growth factors are being incorporated into technically advanced anti-aging formulations that are often sold in the cosmeceuticals category, and the company says the launch of its new range is in response to growing demand. Small but growing anti-aging niche​ A small but growing number of anti-aging skin care products that incorporate the technology are currently on the market, combining other high-tech ingredients such as retinol and peptides. Dr. Bjorn Orvar, ORF Genetics CEO, says that the recent In-Cosmetics event in Amsterdam was chosen as the launching pad for the range in Europe and that the response from the industry was 'fantastic'. Further to this, the company says it will use the Supplier's Day show, held in New Jersey, 13-14 May, as the launching pad for the new range on the North Americain market.

Related topics: Formulation & Science, Skin Care

Related news

Related products

show more

Tagra WS SA50TM Water-Soluble Salicylic Acid

Tagra WS SA50TM Water-Soluble Salicylic Acid

Tagra Biotechnologies | 04-May-2021 | Product Presentation

Watch Tagra’s Water Soluble Salicylic Acid WS SA50™ video and discover a new generation form of Salicylic Acid. Thanks to its water-solubility, WS SA50™...

Sequoia cells to limit male skin ageing

Sequoia cells to limit male skin ageing

Naolys | 30-Apr-2021 | Product Brochure

During SCS Formulate, Naolys, the specialist in plant cell culture, presented their new product dedicated to male skin: Sequoia plant cells that protect...

Regenerative Beauty

Regenerative Beauty

Symrise | Webinar

The past year has ignited a renewed focus and appreciation of nature and the earth, as many consumers are reevaluating their habits to be more conscious...

Register for free

Related suppliers

Follow us


View more